08:00 , Nov 19, 2012 |  BioCentury  |  Regulation

Antibiotics reset

There is a consensus among the U.S. government, industry and the medical community that the failure of antibiotic development to keep pace with the evolution of bacterial pathogens constitutes a public health crisis, and that...
07:00 , May 16, 2011 |  BC Week In Review  |  Company News

Advanced Life infectious news

Advanced Life Sciences said it suspended operations and terminated its staff due to a lack of cash. In January, the company said it would explore strategic alternatives, including an acquisition or partnership. The January decision...
07:00 , Mar 28, 2011 |  BC Week In Review  |  Financial News

Advanced Life financial update

Advanced Life Sciences plans to implement a 1-for-30 reverse stock split, effective March 28. Prior to the split, the company has 323.6 million shares outstanding. Advanced Life Sciences Holdings Inc. (OTCBB:ADLS), Woodridge, Ill.   Business: Infectious,...
08:00 , Mar 3, 2011 |  BC Innovations  |  Strategy

Scots aggregate a ligase platform

For the past three years, Scottish Enterprisehas been working with multiple international academic and commercial labs to investigate therapeutic targets that were regarded as too challenging by many drug development companies. Now, the Scottish government's...
08:00 , Jan 10, 2011 |  BC Week In Review  |  Company News

Advanced Life infectious news

Advanced Life will explore strategic alternatives, including an acquisition or partnership. The decision was based on the company's assessment of the financial resources required to conduct a registration program for its lead compound, Restanza...
08:00 , Nov 15, 2010 |  BC Week In Review  |  Company News

Advanced Life, Abbott, Pfizer infectious news

Advanced Life said it submitted a proposal to NIH's National Institute of Allergy and Infectious Diseases (NIAID) to develop an IV formulation of Restanza cethromycin. The proposal requests $38 million over five years for:...
07:00 , Oct 4, 2010 |  BC Week In Review  |  Financial News

Advanced Life completes warrant exercise

Advanced Life Sciences Holdings Inc. (OTCBB:ADLS), Woodridge, Ill.   Business: Infectious, Cancer, Pulmonary   Date completed: 9/28/10   Type: Warrant exercise   Raised: $1.5 million   Shares: 361,968   Price: $4.20   Shares after offering: 222.1 million   Note: Each warrant entitled the...
07:00 , Sep 6, 2010 |  BioCentury  |  Strategy

Laying siege

sanofi-aventis Group made clear in its conference call last week that it's in no hurry to complete its proposed acquisition of Genzyme Corp. - with the obvious implication that time is on its side. If...
07:00 , Aug 16, 2010 |  BC Week In Review  |  Clinical News

Restanza cethromycin: SPA received

Advanced Life Sciences received an SPA from FDA for a planned Phase III trial to compare Restanza vs. Pfizer's Zithromax azithromycin. The double-blind trial, which is expected to start this year, will compare 300...
07:00 , Aug 2, 2010 |  BC Week In Review  |  Company News

Advanced Life, University of British Columbia deal

Advanced Life Sciences received an exclusive 12-month option to evaluate peptide antibiotics against gram-negative pathogens identified by the university and to receive exclusive, worldwide rights to manufacture, distribute and market products developed under the deal....